{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:57:06Z","timestamp":1790758626049,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005015","name":"South China University of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014857","name":"National Natural Science Foundation of China-Guangdong Joint Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.trsl.2020.04.011","type":"journal-article","created":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T21:49:23Z","timestamp":1589147363000},"page":"28-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Cathepsin B deficiency ameliorates liver lipid deposition, inflammatory cell infiltration, and fibrosis after diet-induced nonalcoholic steatohepatitis"],"prefix":"10.1016","volume":"222","author":[{"given":"Wenqian","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feriel","family":"Benadjaoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongzhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Ping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2020.04.011_bib0001","doi-asserted-by":"crossref","first-page":"11963","DOI":"10.3390\/ijms140611963","article-title":"In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD)","volume":"14","author":"Kanuri","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2020.04.011_bib0002","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.trsl.2020.04.011_bib0003","first-page":"S5","article-title":"The epidemiology of nonalcoholic fatty liver disease in adults","volume":"40","author":"Clark","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.trsl.2020.04.011_bib0004","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejim.2007.02.034","article-title":"Evolving trends in nonalcoholic fatty liver disease","volume":"19","author":"Delgado","year":"2008","journal-title":"Eur J Intern Med"},{"issue":"Suppl","key":"10.1016\/j.trsl.2020.04.011_bib0005","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1194\/jlr.R800089-JLR200","article-title":"Nonalcoholic fatty liver disease","volume":"50","author":"Erickson","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2020.04.011_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/met.2007.0026","article-title":"Nonalcoholic steatohepatitis and the metabolic syndrome","volume":"6","author":"Jiang","year":"2008","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.trsl.2020.04.011_bib0007","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3949\/ccjm.75.10.721","article-title":"Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome","volume":"75","author":"Kim","year":"2008","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.trsl.2020.04.011_bib0008","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.2174\/138161207781039652","article-title":"Non-alcoholic fatty liver disease in the metabolic syndrome","volume":"13","author":"Palasciano","year":"2007","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.trsl.2020.04.011_bib0009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/030089161309900102","article-title":"Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back","volume":"99","author":"Yilmaz","year":"2013","journal-title":"Tumori"},{"key":"10.1016\/j.trsl.2020.04.011_bib0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3748\/wjg.14.185","article-title":"Non-alcoholic fatty liver disease and the metabolic syndrome: an update","volume":"14","author":"Rector","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.trsl.2020.04.011_bib0011","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.hepres.2005.09.006","article-title":"Pathology of nonalcoholic steatohepatitis","volume":"33","author":"Brunt","year":"2005","journal-title":"Hepatol Res"},{"key":"10.1016\/j.trsl.2020.04.011_bib0012","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s10620-014-3031-8","article-title":"OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease","volume":"59","author":"Alkhouri","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.trsl.2020.04.011_bib0013","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000227666","article-title":"Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and\/or liver cirrhosis: potential clinical implications","volume":"54","author":"Leto","year":"1997","journal-title":"Oncology"},{"key":"10.1016\/j.trsl.2020.04.011_bib0014","first-page":"95","article-title":"Collagenolytic cathepsin B and L activity in experimental fibrotic liver and human liver","volume":"76","author":"Yamamoto","year":"1992","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.trsl.2020.04.011_bib0015","first-page":"555","article-title":"Cathepsin D serum mass concentrations in patients with hepatocellular carcinoma and\/or liver cirrhosis","volume":"34","author":"Leto","year":"1996","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1016\/j.trsl.2020.04.011_bib0016","doi-asserted-by":"crossref","first-page":"16239","DOI":"10.1074\/jbc.M113.542407","article-title":"Regulation of TGF-beta1-driven differentiation of human lung fibroblasts: emerging roles of cathepsin B and cystatin C","volume":"289","author":"Kasabova","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2020.04.011_bib0017","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1074\/jbc.M111.272393","article-title":"Cathepsin B overexpression due to acid sphingomyelinase ablation promotes liver fibrosis in Niemann-Pick disease","volume":"287","author":"Moles","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2020.04.011_bib0018","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1172\/JCI200317740","article-title":"Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis","volume":"112","author":"Canbay","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2020.04.011_bib0019","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/hep.22753","article-title":"Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential","volume":"49","author":"Moles","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2020.04.011_bib0020","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1172\/JCI9914","article-title":"Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c","volume":"106","author":"Guicciardi","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2020.04.011_bib0021","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bpg.2011.02.004","article-title":"Animal models for the study of hepatic fibrosis","volume":"25","author":"Starkel","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.trsl.2020.04.011_bib0022","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","article-title":"Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis","volume":"24","author":"Wang","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2020.04.011_bib0023","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.isci.2019.08.014","article-title":"Differential roles of cysteinyl cathepsins in TGF-beta signaling and tissue fibrosis","volume":"19","author":"Zhang","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.trsl.2020.04.011_bib0024","doi-asserted-by":"crossref","first-page":"11530","DOI":"10.1016\/S0021-9258(19)78156-3","article-title":"Human cathepsin S: chromosomal localization, gene structure, and tissue distribution","volume":"269","author":"Shi","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2020.04.011_bib0025","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3892\/br.2014.309","article-title":"Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes","volume":"2","author":"Tomizawa","year":"2014","journal-title":"Biomed Rep"},{"key":"10.1016\/j.trsl.2020.04.011_bib0026","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","article-title":"The interaction of hepatic lipid and glucose metabolism in liver diseases","volume":"56","author":"Bechmann","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.trsl.2020.04.011_bib0027","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1385\/JMN:16:2-3:117","article-title":"Role of CD36 in membrane transport and utilization of long-chain fatty acids by different tissues","volume":"16","author":"Coburn","year":"2001","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.trsl.2020.04.011_bib0028","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.prostaglandins.2006.06.006","article-title":"PPARgamma activation induces CD36 expression and stimulates foam cell like changes in rVSMCs","volume":"80","author":"Lim","year":"2006","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.trsl.2020.04.011_bib0029","doi-asserted-by":"crossref","first-page":"44612","DOI":"10.1038\/srep44612","article-title":"Effect of modulation of PPAR-gamma activity on Kupffer cells M1\/M2 polarization in the development of non-alcoholic fatty liver disease","volume":"7","author":"Luo","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2020.04.011_bib0030","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jhep.2019.06.031","article-title":"Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease","volume":"71","author":"Rosso","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.trsl.2020.04.011_bib0031","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/cmi.2011.53","article-title":"Liver fibrosis: mechanisms of immune-mediated liver injury","volume":"9","author":"Xu","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.trsl.2020.04.011_bib0032","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The myofibroblast: one function, multiple origins","volume":"170","author":"Hinz","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2020.04.011_bib0033","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1074\/jbc.M310349200","article-title":"Regulation of collagenase activities of human cathepsins by glycosaminoglycans","volume":"279","author":"Li","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2020.04.011_bib0034","doi-asserted-by":"crossref","first-page":"28669","DOI":"10.1074\/jbc.M204004200","article-title":"Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate","volume":"277","author":"Li","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2020.04.011_bib0035","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1161\/CIRCULATIONAHA.107.688523","article-title":"Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice","volume":"115","author":"Kitamoto","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2020.04.011_bib0036","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1111\/febs.13499","article-title":"Human cathepsin L, a papain-like collagenase without proline specificity","volume":"282","author":"Korenc","year":"2015","journal-title":"FEBS J"},{"key":"10.1016\/j.trsl.2020.04.011_bib0037","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.HYP.0000164570.20420.67","article-title":"Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction","volume":"45","author":"Ackerman","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2020.04.011_bib0038","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jhep.2008.01.035","article-title":"Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin","volume":"48","author":"Bergheim","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.trsl.2020.04.011_bib0039","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.23122","article-title":"Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice","volume":"50","author":"Spruss","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2020.04.011_bib0040","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jnutbio.2010.04.007","article-title":"Role of tumor necrosis factor alpha (TNFalpha) in the onset of fructose-induced nonalcoholic fatty liver disease in mice","volume":"22","author":"Kanuri","year":"2011","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.trsl.2020.04.011_bib0041","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tem.2008.11.001","article-title":"Cellular fatty acid uptake: a pathway under construction","volume":"20","author":"Su","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.trsl.2020.04.011_bib0042","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C","volume":"60","author":"Miquilena-Colina","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2020.04.011_bib0043","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1053\/j.gastro.2010.02.051","article-title":"Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice","volume":"138","author":"Bieghs","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2020.04.011_bib0044","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/en.2015-1866","article-title":"Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice","volume":"157","author":"Wilson","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.trsl.2020.04.011_bib0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41569-018-0002-3","article-title":"Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials","volume":"15","author":"Liu","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.trsl.2020.04.011_bib0046","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/bbrc.1998.9425","article-title":"Cathepsin B-mediated activation of the proinflammatory caspase-11","volume":"251","author":"Schotte","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2020.04.011_bib0047","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nri2725","article-title":"NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?","volume":"10","author":"Tschopp","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2020.04.011_bib0048","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.011994","article-title":"Cathepsin S deficiency mitigated chronic stress-related neointimal hyperplasia in mice","volume":"8","author":"Wang","year":"2019","journal-title":"J Am Heart Assoc"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420300748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420300748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:40:21Z","timestamp":1761828021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524420300748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":48,"alternative-id":["S1931524420300748"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2020.04.011","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cathepsin B deficiency ameliorates liver lipid deposition, inflammatory cell infiltration, and fibrosis after diet-induced nonalcoholic steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2020.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}